Li Jia-Shang, Su Shu-Lan, Xu Zhuo, Zhao Li-Hui, Fan Ruo-Ying, Guo Jian-Ming, Qian Da-Wei, Duan Jin-Ao
Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, and Jiangsu Key Laboratory for High Technology Research of TCM Formulae, Nanjing University of Chinese Medicine, Nanjing, P.R. China.
Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, and Jiangsu Key Laboratory for High Technology Research of TCM Formulae, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, P.R. China.
Ther Adv Chronic Dis. 2022 Jul 28;13:20406223221091177. doi: 10.1177/20406223221091177. eCollection 2022.
Observational findings achieved that gut microbes mediate human metabolic health and disease risk. The types of intestinal microorganisms depend on the intake of food and drugs and are also related to their metabolic level and genetic factors. Recent studies have shown that chronic inflammatory pain is closely related to intestinal microbial homeostasis. Compared with the normal intestinal flora, the composition of intestinal flora in patients with chronic inflammatory pain had significant changes in , , , etc. At the same time, short-chain fatty acids and amino acids, the metabolites of intestinal microorganisms, can regulate neural signal molecules and signaling pathways, thus affecting the development trend of chronic inflammatory pain. Glucocorticoids and non-steroidal anti-inflammatory drugs in the treatment of chronic inflammatory pain, the main mechanism is to affect the secretion of inflammatory factors and the abundance of intestinal bacteria. This article reviews the relationship between intestinal microorganisms and their metabolites on chronic inflammatory pain and the possible mechanism.
Arch Ital Urol Androl. 2019-1-18
World J Gastroenterol. 2014-12-28
Front Nutr. 2021-1-13
Front Cardiovasc Med. 2022-7-1
Front Pharmacol. 2023-8-23
Appl Microbiol Biotechnol. 2023-2
J Oral Facial Pain Headache. 2025-3
Mol Neurobiol. 2025-5
J Headache Pain. 2024-11-11
Front Cell Infect Microbiol. 2022
Front Cell Infect Microbiol. 2021
J Biochem Mol Toxicol. 2021-4
J Trauma Acute Care Surg. 2021-1-1
Drug Deliv Transl Res. 2021-6
Benef Microbes. 2020-9-1